Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Is a Short Squeeze on the Cards for WELL Health Stock?

Published 2021-06-09, 08:50 a/m
Updated 2021-06-09, 09:16 a/m
Is a Short Squeeze on the Cards for WELL Health Stock?

Is a Short Squeeze on the Cards for WELL Health Stock?

Short-sellers have had a tough time in recent days. Retail traders have initiated multiple short squeezes on stocks such as AMC Entertainment, BlackBerry, GameStop (NYSE:GME), Sundial Growers, and Clover Health. In fact, Clover Health stock was up 85% yesterday and has surged over 20% in pre-market trading today. Clover Health’s trading volume was around 723 million shares on June 8, and it’s quite evident that the Reddit army has taken charge, sending the stock to record highs.

Another stock that is on the radar of retail traders is Canadian company WELL Health Technologies (TSX:WELL). While WELL stock has a high short-interest ratio, it is also fundamentally strong compared to the other stocks discussed above, making it a better bet right now.

Why is WELL Health stock a solid long-term bet? WELL Health continues to grow rapidly via accretive acquisitions. It just completed a $206 million acquisition of “MyHealth,” making it the largest private clinic operator in Canada. This is one of many major acquisitions the company has closed in 2021. Earlier this year, it announced a $372.9 million acquisition of CRH (LON:CRH) Medical, which significantly increased the company’s footprint south of the border.

The CRH Medical acquisitions led to JP Morgan extending an existing credit line by US$100 million, while Royal Bank of Canada provided another $200 million via a secured credit facility to close the MyHealth buyout.

This all comes on the back of a recent $305 million financing that was priced at a 25% premium to WELL Health’s stock price. The investment round was led by the 29th richest man in the world, Sir Li Ka-Shing. Since then, the company has been on an acquisition spree, positioning itself as a true multi-channel digital healthcare leader.

These developments have garnered attention from major institutions like JP Morgan and RBC as well as from renowned law firm Fenwick & West, which helped companies like Facebook (NASDAQ:FB), Amazon (NASDAQ:AMZN), Cisco (NASDAQ:CSCO), and Coinbase with their IPOs.

WELL Health has officially engaged Fenwick & West to assist them with an IPO to list on the NASDAQ in Q4 of 2021. Investors should note that digital health companies in the U.S. are trading at a far higher multiple compared to WELL Health. In fact, WELL stock is trading at a significant discount and should gain momentum to end the year at a higher price.

What’s next for WELL Health investors? While most meme stocks have underperformed the broader markets prior to the short squeezes, WELL Health stock has been on an absolute tear. In fact, the stock is up a staggering 8,000% since its IPO. In the last two trading sessions, shares have surged close to 14%.

Even after its phenomenal performance, WELL Health shares are trading 12% below all-time highs. Its low price-to-sales multiple and rising profit margins make it a top bet for 2021 and beyond. While most meme stocks will take a breather once normalcy returns, WELL Health should continue to move higher and generate outsized returns to investors.

The post Is a Short Squeeze on the Cards for WELL Health Stock? appeared first on The Motley Fool Canada.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. JPMorgan Chase (NYSE:JPM) is an advertising partner of The Ascent, a Motley Fool company. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. The Motley Fool owns shares of and recommends Amazon and Facebook. The Motley Fool recommends BlackBerry and recommends the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.